Fondazione Gianni Benzi carries on its involvement in providing useful and correct information on the current health emergency (read more on our initiative here).
On the 30th January 2020, the European Commission launched a request for expressions with the aim to advance knowledge for the clinical and public health response to the [COVID-19] epidemic, with a budget which was subsequently increased up to €47.5 million considering the scale of the outbreak and the potential of the research projects submitted.
Seventeen research projects were shortlisted for funding. These projects are expected to advance our understanding of the novel coronavirus (SARS-CoV-2), to contribute to more efficient clinical management of patients infected with the virus, and to the public health preparedness and response to the outbreak. Research teams will share data rapidly so that results can immediately inform the public health system.
Such rapid reaction is made possible by the standing budget line for emergency research funds that the Commission maintains as part of the Horizon 2020 annual work programmes for Health research.
Moreover, several EU funded ongoing projects (both Framework Programme 7 and Horizon 2020) are currently contributing to the European and global response activities to outbreaks.
Additionally, the Commission is working with other research funds through the “Global research collaboration for infectious disease preparedness” (GloPID-R) network which facilitate a rapid and effective measures to fight this outbreak.
As already announced, on the 3rd March a special fast track call for research proposals was launched by the Innovative Medicines Initiative (IMI). The IMI call invites proposals for projects to address the development of treatments to rapidly respond to the current COVID-19 outbreak and/or future coronavirus outbreaks, including potential drugs that are already at a very advanced stage of development, or an existing, approved drug that could be ‘repurposed’ as well as strategies to address drug resistance; moreover, the Call supports proposals on the development of diagnostic tests to rapidly and reliably identify people infected with the coronavirus and for use in clinical trials of new drugs.
Preventive vaccines are not included in the Call, to avoid duplications in this area.
Discover more on these initiatives here.
Stay tuned for other useful news!